Home » Topics » BioWorld

BioWorld
RSS

AMBISOME APPROVED FOR SALE IN MEXICO, ITALY

Oct. 31, 1991

PRODUCT SALES DRIVE CHIRON EARNINGS

Oct. 31, 1991

COR RAISES $36.5 MILLION IN OFFERING

Oct. 31, 1991

CREATIVE BIO RAISES $14 MILLION IN STOCK SALE

Oct. 31, 1991

ANTICIPATED DATA PROPELS SYNERGEN STOCK

Oct. 31, 1991

GENENTECH SEEKS BUYER FOR GLC ASSOCIATES

Oct. 30, 1991

IMMUNE RESPONSE RAISES $44 MILLION

Oct. 30, 1991

MAGAININ FILES FOR 2 MILLION-SHARE IPO

Oct. 30, 1991

ANALYST UPGRADES IMMUNEX RATING

Oct. 30, 1991

CAL BIO RAISES $56.9 MILLION IN OFFERING

Oct. 30, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...